Opus Genetics, Inc. (IRD) insider trading
Over the last 12 months, 1 insider bought $324K and 7 insiders sold $19.3M of Opus Genetics, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Sep 30, 2026: Foundation Fighting Blindness Retinal Degeneration Fund sold 556,000 shares ($2.76M)
- Sep 3, 2026: Gagnon Robert E. sold 28,000 shares ($127K)
- Jul 23, 2026: Gagnon Robert E. sold 7,783 shares ($23.0K)
- Jul 23, 2026: Magrath George sold 9,475 shares ($28.0K)
- Jul 23, 2026: Schachle Joseph K sold 4,644 shares ($13.7K)
- Jul 23, 2026: Yerxa Benjamin R sold 7,429 shares ($22.1K)
- May 18, 2026: Foundation Fighting Blindness Retinal Degeneration Fund sold 1,700,000 shares ($7.40M)
- Apr 23, 2026: Gagnon Robert E. sold 7,842 shares ($40.6K)
- Apr 23, 2026: Jayagopal Ashwath sold 7,542 shares ($39.1K)
- Apr 23, 2026: Magrath George sold 9,511 shares ($49.6K)